TSO3 (TSE:TOS) was downgraded by investment analysts at National Bank Financial from an “outperform” rating to a “sector perform” rating in a note issued to investors on Monday. They presently have a C$2.25 target price on the stock, down from their prior target price of C$5.50. National Bank Financial’s target price would suggest a potential upside of 43.31% from the stock’s current price.
Other analysts have also recently issued research reports about the company. Desjardins cut TSO3 from a “buy” rating to a “hold” rating in a report on Friday, January 26th. Royal Bank of Canada cut TSO3 from an “outperform” rating to a “sector perform” rating and dropped their price objective for the stock from C$4.25 to C$2.00 in a report on Friday, January 26th. Finally, Canaccord Genuity cut TSO3 from a “buy” rating to a “speculative buy” rating and dropped their price objective for the stock from C$4.25 to C$2.75 in a report on Friday, January 26th. Four research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of C$2.75.
TSO3 (TSE:TOS) opened at C$1.57 on Monday. The firm has a market capitalization of $146.10, a price-to-earnings ratio of -14.27 and a beta of 1.52. TSO3 has a 12 month low of C$1.55 and a 12 month high of C$3.36.
TSO3 (TSE:TOS) last issued its quarterly earnings data on Monday, November 6th. The company reported C($0.03) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of C($0.03). TSO3 had a negative return on equity of 48.85% and a negative net margin of 34.69%.
COPYRIGHT VIOLATION WARNING: “National Bank Financial Downgrades TSO3 (TOS) to Sector Perform” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/01/31/national-bank-financial-downgrades-tso3-tos-to-sector-perform.html.
TSO3 Company Profile
TSO3 Inc is a Canada-based company engaged in the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment.
Receive News & Ratings for TSO3 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 and related companies with MarketBeat.com's FREE daily email newsletter.